The global collagen peptides market is projected to grow from USD 699 million in 2023 to USD 922 million by 2028, registering a CAGR of 5.7% during the forecast period. This growth is primarily driven by rising consumer awareness about health and wellness, along with the expanding range of applications for collagen peptides across various industries.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=248590980
Increasing Demand for Collagen Peptides in Medical Applications to Drive Market Growth
Collagen peptides are gaining traction in medical, dental, and pharmaceutical applications due to their multifunctional properties. They serve as natural biomaterials with wound-healing, astringent, and drug-supporting characteristics, making them ideal for use in medical treatments. Collagen is widely used in hemostatic and wound dressings, and its role in tissue engineering and regenerative medicine is becoming increasingly significant.
Thanks to properties such as biocompatibility, biodegradability, and structural versatility, collagen has become one of the most important biomaterials in modern healthcare. Ongoing biotechnological advancements have further expanded its use, particularly the adoption of marine collagen as a functional biomaterial in pharmaceutical formulations. This growing utilization underscores collagen’s potential to revolutionize the medical and pharmaceutical industries.
Bovine Source Segment to Hold a Significant Market Share
By source, the bovine segment is expected to maintain a substantial share of the collagen peptides market throughout the forecast period. Bovine-derived collagen peptides have been extensively studied and commercialized, making them widely accepted in the market.
Their popularity is supported by factors such as high availability, cost-effectiveness, and strong biocompatibility. Consumers favor bovine collagen due to its health and beauty benefits — including skin hydration, improved gut health, enhanced muscle strength, and support for hair and nail growth. These advantages are fueling the expansion of the bovine collagen segment globally.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=248590980
Asia Pacific to Lead Market Growth
The Asia Pacific region is projected to be a key driver of market growth for collagen peptides in the coming years. The region’s expanding livestock industry, supported by urbanization, population growth, and increasing demand for animal-based products, has created a favorable environment for collagen production and export.
Countries such as China have emerged as major exporters of collagen globally. Key players operating in this region include Nitta Gelatin Inc. (Japan), Tessenderlo Group (Belgium), Holista Colltech (Australia), Darling Ingredients (US), Foodmate Co., Ltd. (China), and Amicogen Inc. (South Korea).
The market landscape features intense competition and innovation, with leading companies focusing on product development, strategic collaborations, and regional expansion to strengthen their market presence in the collagen peptides industry.
